TCB selected to receive H2020 grant for the development of next-generation allogeneic approach Aug. 7, 2017
Vaccibody files German clinical trial application for cancer neoantigen vaccine VB10.NEO Aug. 4, 2017
Antigen Express and Merck & Co. agree to test AE-37 with Keytruda in triple-negative breast cancer Aug. 1, 2017
RSS